Center Laboratories, Inc. (TPEX:4123)
32.40
+0.45 (1.41%)
Aug 19, 2026, 1:30 PM CST
Center Laboratories Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,657 | 1,516 | 1,618 | 1,394 | 767.72 | 500.11 |
Revenue Growth | 3.63% | -6.29% | 16.06% | 81.58% | 53.51% | -30.25% |
Gross Profit Gross Profit Growth | 716.93 | 621.26 | 748.95 | 618.09 | 406.27 | 259.66 |
Operating Income Operating Income Growth | 55.59 | -361.62 | 234.06 | 78.56 | 284.12 | -254.15 |
Net Income Net Income Growth | 1,019 | 9,323 | -1,104 | -995.42 | 102.22 | 1,816 |
Earnings Per Share EPS Growth | 1.29 | 10.90 | -1.41 | -1.36 | 0.14 | 2.52 |
EPS Growth | - | - | - | - | -94.29% | -53.20% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Fenghua Sector/Department Fenghua Sector/Department Growth | 576.17 | 646.91 | 446.06 | - | - |
Pharmaceutical Division Pharmaceutical Division Growth | 941.1 | 971.71 | 950.53 | 767.8 | 500.31 |
Adjustment and Write-Off Adjustment and Write-Off Growth | -24.26 | -21.57 | -18.72 | -1.52 | -1.64 |
Shengzhi Venture Shengzhi Venture Growth | 23.17 | 20.82 | 16.14 | - | - |
Total Total Growth | 1,516 | 1,618 | 1,394 | 767.72 | 500.11 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,606 | 662.82 | 2,050 | 3,424 | 2,348 | 4,849 |
Total Debt Total Debt Growth | 3,890 | 4,704 | 6,530 | 5,621 | 3,468 | 5,362 |
Net Cash (Debt) Net Cash Growth | -283.5 | -4,041 | -4,480 | -2,197 | -1,120 | -512.52 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.33 | -4.68 | -5.72 | -3.00 | -1.58 | -0.70 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 283.16 | 27.16 | 394.74 | -963.44 | -189.88 | -358.14 |
Capital Expenditures CapEx Growth | -154.71 | -205.5 | -174.17 | -169.4 | -7.28 | -7.55 |
Free Cash Flow Free Cash Flow Growth | 128.45 | -178.34 | 220.56 | -1,133 | -197.16 | -365.69 |
Free Cash Flow Growth | 2944.47% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 43.28% | 40.98% | 46.29% | 44.34% | 52.92% | 51.92% |
Operating Margin | 3.36% | -23.85% | 14.47% | 5.63% | 37.01% | -50.82% |
Pretax Margin | 98.55% | 763.01% | -72.32% | -79.91% | -76.71% | 519.02% |
Profit Margin | 61.51% | 614.88% | -68.22% | -71.41% | 13.31% | 363.16% |
FCF Margin | 7.75% | -11.76% | 13.63% | -81.27% | -25.68% | -73.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.664 | 1.664 | 0.714 | 1.360 | 0.825 | 1.799 |
Dividend Per Share Growth | 129.71% | 132.88% | -47.46% | 64.88% | -54.16% | 83.29% |
Dividend Yield | 5.21% | 4.42% | 1.93% | 3.75% | 2.38% | 4.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.20 | 3.33 | - | - | 275.22 | 16.82 |
Forward PE | - | 21.73 | 21.73 | 21.73 | 21.73 | 21.73 |
P/FCF Ratio | 197.71 | - | 143.23 | - | - | - |
PS Ratio | 15.33 | 20.48 | 19.53 | 21.97 | 36.64 | 61.10 |